Compare NSRX & WIMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NSRX | WIMI |
|---|---|---|
| Founded | 2019 | 2015 |
| Country | Israel | China |
| Employees | 7 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.2M | 31.9M |
| IPO Year | N/A | 2019 |
| Metric | NSRX | WIMI |
|---|---|---|
| Price | $3.20 | $1.74 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $19.67 | N/A |
| AVG Volume (30 Days) | 52.6K | ★ 311.5K |
| Earning Date | 03-25-2026 | 04-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $1.24 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.98 | $1.46 |
| 52 Week High | $9.99 | $5.65 |
| Indicator | NSRX | WIMI |
|---|---|---|
| Relative Strength Index (RSI) | 54.73 | 55.06 |
| Support Level | $2.04 | $1.58 |
| Resistance Level | $3.48 | $2.06 |
| Average True Range (ATR) | 0.25 | 0.11 |
| MACD | 0.02 | 0.03 |
| Stochastic Oscillator | 63.64 | 84.85 |
Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.
WiMi Hologram Cloud Inc and its subsidiaries offer augmented reality (AR) based holographic services and products to cater to its customers. Its AR service and product offerings consist of holographic AR advertising services and holographic AR entertainment products. It is also into the semiconductor business, in which the company provides central processing algorithm services and computer chip products to enterprise customers and the sales of comprehensive solutions for central processing algorithms and related services with software and hardware integration. The company reports in three segments: AR advertising, AR entertainment, and Semiconductor. Its geographical segments are Mainland China, Hong Kong, and International.